Table 2.

Biochemical characteristics of study subjects

	Controls			Cases
Parameters	Male	Female	Total	Male	Female	Total	p Value
FBS (mg/dL)	99.2±7.9	95.9±10.1	97.6±9.1	141.7±43.2	138.8±36.4	140.4±39.9	<0.001
PPBS(mg/dL)	117.5±14.7	119.5±19.9	118.5±17.4	219.4±57.2	219.2±63.0	219.4±59.6	<0.001
HbA1c (%)	5.6±0.4	5.4±0.5	5.6±0.5	7.37±1.2	7.3±1.0	7.3±1.1	<0.001
TC (mg/dL)	181.3±29.3	173.9±26.8	177.7±28.2	214.1±28.5	197.0±19.7	206.0±26.0*	<0.001
TG (mg/dL)	142.8±40.8	127.2±26.7	135.7±35.4*	188.9±53.6	174.1±31.9	181.9±45.0	<0.001
HDL-C (mg/dL)	48.9±6.5	52.5±10.3	50.6±8.7	46.57±6.6	45.63±4.8	46.1±5.8	<0.001
LDL-C (mg/dL)	102.4±23.4	96.6±24.1	99.6±23.8	129.4±27.7	116.6±19.1	123.3±24.7*	<0.001
VLDL-C (mg/dl)	28.6±8.0	26.3±6.2	27.5±7.3	38.0±10.7	34.73±6.3	36.5±9.0	<0.001
ADA1 (U/L)	8.0 ±2.24	8.62±2.15	8.3±2.21	14.19±4.89	14.12±4.63	14.16 ±4.74	<0.001
ADA2 (U/L)	12.29±2.23	12.11±2.13	12.2 ±2.17	21.9±4.42	20.95±4.79	21.48 ±4.60	<0.001
Total ADA	20.2±3.0	20.68±3.51	20.46 ±3.27	36.3±7.37	34.63±7.7	35.55 ±7.53	<0.001

p<0.05 is significant.

*Significant difference between male and female within controls and case groups, at the level of 0.05.

ADA, adenosine deaminase; FBS, fasting blood sugar; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; PPBS, postprandial blood sugar; TC, total cholesterol; TG, triglyceride; VLDL-C, very low-density lipoprotein cholesterol.